- Home
- Publications
- Publication Search
- Publication Details
Title
Gut microbiome and cancer immunotherapy
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-30
DOI
10.1002/jcp.29359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- Hyperprogression as a Distinct Outcome after Immunotherapy
- (2018) J. Fuentes-Antrás et al. CANCER TREATMENT REVIEWS
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Immuno-oncology-101: overview of major concepts and translational perspectives
- (2018) B. Allard et al. SEMINARS IN CANCER BIOLOGY
- Changes of microbiome profile during nivolumab treatment in NSCLC patients.
- (2018) Andrea Botticelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting
- (2018) F. De Santis et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
- (2017) Sohn Kim et al. IMMUNOLOGICAL REVIEWS
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome
- (2016) J. M. Pitt et al. CANCER RESEARCH
- Management of toxicities of immune checkpoint inhibitors
- (2016) Lavinia Spain et al. CANCER TREATMENT REVIEWS
- Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations
- (2016) Christoph A. Thaiss et al. CELL
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Revised Estimates for the Number of Human and Bacteria Cells in the Body
- (2016) Ron Sender et al. PLOS BIOLOGY
- Proton pump inhibitors alter the composition of the gut microbiota
- (2015) Matthew A Jackson et al. GUT
- Immunological landscape and immunotherapy of hepatocellular carcinoma
- (2015) Jesús Prieto et al. Nature Reviews Gastroenterology & Hepatology
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Cancer and the gut microbiota: An unexpected link
- (2015) Laurence Zitvogel et al. Science Translational Medicine
- Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
- (2015) Luca Miele et al. Current Cardiology Reports
- Structure and function of the healthy pre-adolescent pediatric gut microbiome
- (2015) Emily B. Hollister et al. Microbiome
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- Plasmacytoid Dendritic Cells Mediate Anti-inflammatory Responses to a Gut Commensal Molecule via Both Innate and Adaptive Mechanisms
- (2014) Suryasarathi Dasgupta et al. Cell Host & Microbe
- Intestinal microbiota: unexpected alliance with tumor therapy
- (2014) Naofumi Mukaida Immunotherapy
- The gut microbiota and inflammatory bowel disease
- (2014) Katsuyoshi Matsuoka et al. Seminars in Immunopathology
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Diet rapidly and reproducibly alters the human gut microbiome
- (2013) Lawrence A. David et al. NATURE
- Control of pathogens and pathobionts by the gut microbiota
- (2013) Nobuhiko Kamada et al. NATURE IMMUNOLOGY
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Diversity, stability and resilience of the human gut microbiota
- (2012) Catherine A. Lozupone et al. NATURE
- Human gut microbiome viewed across age and geography
- (2012) Tanya Yatsunenko et al. NATURE
- The Application of Ecological Theory Toward an Understanding of the Human Microbiome
- (2012) E. K. Costello et al. SCIENCE
- Microbiota, Disease, and Back to Health: A Metastable Journey
- (2012) R. Blumberg et al. Science Translational Medicine
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects
- (2010) Robin F. J. Benus et al. BRITISH JOURNAL OF NUTRITION
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
- (2009) Ivaylo I. Ivanov et al. CELL
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
- (2009) J. Weber et al. CLINICAL CANCER RESEARCH
- Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii
- (2008) Carlett Ramirez-Farias et al. BRITISH JOURNAL OF NUTRITION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started